Non-Invasive Patient Self-Administration – Expanding Therapeutic Options for Patients With Earlier Stage Disease; Making Strides Forward in Drug Delivery & Dosing

Time: 12:05 pm
day: Day One


  • Enabling identification of patients with earlier stage disease through expansion of sophisticated screening and diagnosis technologies employed outside the retinal surgeons offices
  • What advances are in development for patient self-administration that have potential to induce a paradigm shift from the current “watch and wait” management of these patients?
  • Currently available patient administered treatments
  • Existing targets – antiVEGF, corticosteroids
  • Emerging new targets – integrin antagonists
  • Case study: OTT166